Jaguar Land Rover Adjusts India EV Manufacturing Strategy, Impacting Tata's Electric Mobility Plans

Developments have emerged regarding the manufacturing strategies of Jaguar Land Rover (JLR) in India, which are consequently influencing the electric vehicle (EV) ambitions of its parent company, Tata Motors. Reports indicate that JLR has shelved its plans to manufacture electric vehicles at Tata Motors’ upcoming $1 billion factory in Tamil Nadu. This decision stems from the British luxury car unit's inability to achieve the desired price-quality equilibrium for locally sourced EV components. Furthermore, sources suggest that slowing demand for electric cars has also contributed to this strategic shift.

According to sources familiar with the matter, work on JLR's India EV project has been suspended for approximately two months. The now-shelved plans envisioned JLR manufacturing over 70,000 electric cars at the new facility, alongside Tata's EV unit building 25,000. The vehicles were intended to share a common platform, with some components being jointly sourced. Tata Motors began construction of the plant, which will also assemble non-EVs, in September and anticipates an annual production capacity exceeding 250,000 cars within 5-7 years.

The repercussions of JLR's altered strategy extend to Tata Passenger Electric Mobility (TPEM). Sources suggest that the delay in JLR's EV manufacturing plans is expected to postpone the launch of Tata's premium Avinya models. Notably, Tata's EV unit was reportedly making changes to its designs as the economic viability of its original plan was contingent on JLR's participation. Tata had already pushed back the launch of its Avinya EV to 2026-2027 from an earlier timeline this year, and the current situation may precipitate further delays.

In response to these reports, Tata Motors issued a statement clarifying that the production timelines and the selection of models to be manufactured at the Tamil Nadu plant will be aligned with the broader strategies and market requirements of both Tata and JLR. A company spokesperson affirmed that the $1 billion greenfield facility in Ranipet will produce next-generation cars and sport utility vehicles (SUVs) for both entities, catering to domestic and international markets. The spokesperson further stated that Tata Motors continues to explore ways to optimise its supply chain for both its own vehicles and those of JLR.

Tata Motors’ statement underscores its commitment to the new Tamil Nadu facility, which was initially announced in March 2024 with an investment of approximately ₹9,000 crore. This initiative was viewed as integral to the Tata Group's broader objective of transitioning JLR into an EV-focused brand.

The decision by JLR occurs amidst a backdrop of global car brands reassessing their electrification strategies in the face of intense competition from Chinese manufacturers, a shifting consumer preference towards hybrid vehicles, and governments easing emission regulations and EV sales targets. In India's burgeoning EV market, where Tata Motors currently holds the largest share, the company faces increasing competition from rivals launching new, feature-rich models with extended driving ranges. Additionally, Tesla is finalising plans to enter the Indian market, which is the world's third-largest for car sales.

While JLR has shelved its immediate EV manufacturing plans in Tamil Nadu, it does assemble some of its models, such as the Range Rover SUVs, at Tata's plant in Pune. The recent developments indicate a recalibration of JLR's India strategy, primarily driven by economic considerations related to local sourcing of EV components. This adjustment will inevitably have ramifications for Tata Motors' ambitious electric mobility roadmap and the anticipated launch of its premium Avinya range. Market participants will be keenly observing how these revised plans unfold in the evolving Indian automotive landscape.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.